CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth. Lin Y, Zhao Y, Chen M, Li Z, et al. BMC Cancer 2023;23:479.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lin Y, Zhao Y, Chen M, Li Z, et al. CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth. BMC Cancer 2023;23:479.
PMID: 37237269